Study protocol for a randomized controlled trial: Qiliqiangxin in heart failUre: assESsment of reduction in morTality (QUEST)

• Main Authors: Wenming Yao (Author), Iokfai Cheang (Author), Shengen Liao (Author), Yanli Zhou (Author), Fang Zhou (Author), Dongjie Xu (Author), Zhenhua Jia (Author), Liping Chang (Author), Haifeng Zhang (Author), Xinli Li (Author)
• Format: Book
• Published: BMC, 2020-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Qiliqiangxin (QLQX) capsule is a Traditional Chinese Medicine (TCM) that has been approved in China for the treatment of chronic heart failure (CHF). Our previous study showed with a background of standard HF treatment, QLQX capsules further reduced the levels of NT-proBNP and th...